Portfolio company
Scipher Medicine
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops blood tests that use artificial intelligence to match autoimmune disease patients with effective therapies for clinicians and pharmaceutical partners.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Graph Therapeutics
This company develops artificial intelligence technology to create targeted therapies and biomarkers for patients with immune-mediated diseases.
Hepta Bio
This company develops AI-powered blood tests for chronic liver disease diagnostics to assist clinicians and pharmaceutical companies with patient identification and monitoring.
Aqtual
This company develops blood-based tests to predict therapy response and monitor chronic diseases like rheumatoid arthritis and cancer for healthcare providers.
Progentec Diagnostics
This company develops biomarker tests and digital monitoring tools for clinicians to manage patients with autoimmune diseases like lupus and multiple sclerosis.
Ditto Biosciences
The company develops parasite-derived protein therapies for pharmaceutical and biotechnology partners to treat patients with autoimmune diseases using an artificial intelligence platform.
Epana Bio
This company develops precision T-cell engagers and biologics using artificial intelligence and genomics to treat patients with autoimmune diseases.
InterVenn BioSciences
This company develops glycoproteomic diagnostic tests and an AI-driven analysis platform for clinicians and biopharmaceutical partners to improve disease detection and treatment.
Presymptom Health
This company develops AI-driven diagnostic tests and software that detect infection and sepsis in patients for use by healthcare providers and clinical labs.
